Hospira's generic Zosyn enters market
LAKE FOREST, Ill. Drug maker Hospira has launched a generic treatment for bacterial infections, Hospira said Thursday.
The company, which specializes in generic injectables, announced the launch of piperacillin and tazobactam for injection. The drug is a generic version of Pfizer’s Zosyn.
Various versions of the drug had sales of $797 million during the 12-month period ended in August, according to IMS Health. Sandoz, the generics division of Novartis, also launched its own version of the drug Thursday.